Journal article
Recommendations for the implementation of genetic testing for metastatic prostate cancer patients in Canada
Abstract
INTRODUCTION: Genetic testing in advanced prostate cancer is rapidly moving to become standard of care. Testing for genetic alterations in genes involved in DNA repair pathways, particularly those implicated in the homologous recombination repair (HRR) pathway, in patients with metastatic prostate cancer (mPCa) can inform selection of optimal therapies, as well as provide information about familial cancer risks; however, there are currently no …
Authors
Selvarajah S; Schrader KA; Kolinsky MP; Rendon RA; El Hallani S; Fleshner NE; Hotte SJ; Lorentz J; Panabaker K; Perrier R
Journal
Canadian Urological Association Journal, Vol. 16, No. 10, pp. 321–332
Publisher
Canadian Urological Association Journal
Publication Date
10 2022
DOI
10.5489/cuaj.7954
ISSN
1911-6470